ECDC has produced these guidelines which aim to support the implementation of tailored surveillance for invasive mosquito species of public health relevance.
Despite efforts to prevent new HIV infections, more than 27 000 people were newly diagnosed with HIV in the European Union (EU) and the European Economic Area (EEA) in 2010.
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.
This document outlines the steps necessary to implement a comprehensive and effective control programme. It also offers advice on how to monitor and evaluate such programmes in order to ensure their effectiveness.
Following an outbreak of chikungunya in the area of Ravenna, Italy in Summer 2007 and the increasing presence of Aedes albopictus mosquitoes in Europe, ECDC has prepared a Chikungunya Communications Toolkit. It provides template materials containing background information and practical advice on chikungunya prevention and control and is targeting the general public, travellers and health practitioners.